{
    "TCGA-3C-AAAU": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "1808",
            "bcr_followup_barcode": "TCGA-3C-AAAU-F68069"
        }
    ],
    "TCGA-A2-A04P": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "102",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A04P-F71021"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Axilla",
            "days_to_new_tumor_event_after_initial_treatment": "179",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "179",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative",
            "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value": "1.0",
            "bcr_followup_barcode": "TCGA-A2-A04P-F71021"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "180",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A04P-F71021"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "313",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A04P-F71021"
        },
        {}
    ],
    "TCGA-A2-A04V": [
        {}
    ],
    "TCGA-A2-A0CK": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "LEFT BREAST",
            "days_to_new_tumor_event_after_initial_treatment": "1364",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "1409",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "50-59%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "10-19%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative",
            "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value": "1.2",
            "bcr_followup_barcode": "TCGA-A2-A0CK-F42396"
        }
    ],
    "TCGA-A2-A0CM": [
        {}
    ],
    "TCGA-A2-A0CS": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative",
            "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value": "1.09"
        }
    ],
    "TCGA-A2-A0EW": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "1353",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A0EW-F59511"
        }
    ],
    "TCGA-A2-A0SV": [
        {}
    ],
    "TCGA-A2-A0SW": [
        {}
    ],
    "TCGA-A2-A0T2": [
        {}
    ],
    "TCGA-A2-A25B": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "1290",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "[Unknown]",
            "additional_pharmaceutical_therapy": "[Unknown]",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "bcr_followup_barcode": "TCGA-A2-A25B-F70679"
        }
    ],
    "TCGA-A2-A25E": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Left Chest Wall",
            "days_to_new_tumor_event_after_initial_treatment": "2989",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "3024",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "90-99%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+",
            "bcr_followup_barcode": "TCGA-A2-A25E-F44982"
        }
    ],
    "TCGA-A2-A3XS": [
        {}
    ],
    "TCGA-A2-A3XU": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "574",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "574",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A3XU-F34704"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Breast",
            "days_to_new_tumor_event_after_initial_treatment": "596",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "bcr_followup_barcode": "TCGA-A2-A3XU-F34704"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Chest wall, Breast Recurrence",
            "days_to_new_tumor_event_after_initial_treatment": "596",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "bcr_followup_barcode": "TCGA-A2-A3XU-F34704"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Chest wall",
            "days_to_new_tumor_event_after_initial_treatment": "667",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Breast recurrence",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "596",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES"
        }
    ],
    "TCGA-A2-A3XY": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Brain",
            "days_to_new_tumor_event_after_initial_treatment": "1072",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-A2-A3XY-F55836"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "802",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A3XY-F43311"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Mediastinal and Supraclavicular Lymph Nodes",
            "days_to_new_tumor_event_after_initial_treatment": "813",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-A2-A3XY-F43311"
        }
    ],
    "TCGA-A7-A13G": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Skin, right leg",
            "days_to_new_tumor_event_after_initial_treatment": "586",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "586",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-A7-A13G-F35039"
        }
    ],
    "TCGA-A7-A13H": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Skin lesion-Basal Cell Left Lower Lateral Back",
            "days_to_new_tumor_event_after_initial_treatment": "795",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "840",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-A7-A13H-F41651"
        }
    ],
    "TCGA-A7-A26H": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "311",
            "bcr_followup_barcode": "TCGA-A7-A26H-F39890"
        }
    ],
    "TCGA-A7-A3RF": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "174",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-A7-A3RF-F40413"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "192",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-A7-A3RF-F40413"
        }
    ],
    "TCGA-A7-A425": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Left Breast",
            "days_to_new_tumor_event_after_initial_treatment": "419",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "419",
            "additional_radiation_therapy": "[Unknown]",
            "additional_pharmaceutical_therapy": "[Unknown]",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "90-99%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+",
            "bcr_followup_barcode": "TCGA-A7-A425-F41648"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "443",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "[Unknown]",
            "additional_pharmaceutical_therapy": "[Unknown]",
            "bcr_followup_barcode": "TCGA-A7-A425-F41648"
        }
    ],
    "TCGA-A8-A06Y": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "791",
            "bcr_followup_barcode": "TCGA-A8-A06Y-F40819"
        },
        {
            "days_to_new_tumor_event_after_initial_treatment": "791",
            "bcr_followup_barcode": "TCGA-A8-A06Y-F40819"
        }
    ],
    "TCGA-A8-A08O": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "762",
            "bcr_followup_barcode": "TCGA-A8-A08O-F40848"
        },
        {
            "days_to_new_tumor_event_after_initial_treatment": "762",
            "bcr_followup_barcode": "TCGA-A8-A08O-F40848"
        }
    ],
    "TCGA-A8-A08T": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "2557",
            "bcr_followup_barcode": "TCGA-A8-A08T-F40559"
        }
    ],
    "TCGA-A8-A08X": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "366",
            "bcr_followup_barcode": "TCGA-A8-A08X-F40558"
        }
    ],
    "TCGA-A8-A091": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "243",
            "bcr_followup_barcode": "TCGA-A8-A091-F40557"
        }
    ],
    "TCGA-AC-A2B8": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Rectum",
            "days_to_new_tumor_event_after_initial_treatment": "654",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "672",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-AC-A2B8-F43210"
        }
    ],
    "TCGA-AC-A2FE": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "2496",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-AC-A2FE-F47725"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "766",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "766",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-AC-A2FE-F47723"
        }
    ],
    "TCGA-AC-A2FM": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Bone Marrow",
            "days_to_new_tumor_event_after_initial_treatment": "780",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-AC-A2FM-F43237"
        }
    ],
    "TCGA-AC-A2QJ": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "237",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-AC-A2QJ-F44021"
        }
    ],
    "TCGA-AO-A0J5": [
        {}
    ],
    "TCGA-AR-A0TY": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        }
    ],
    "TCGA-AR-A0TZ": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "1313",
            "bcr_followup_barcode": "TCGA-AR-A0TZ-F49471"
        },
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "70-79%",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        }
    ],
    "TCGA-AR-A0U2": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "70-79%",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "2+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative",
            "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value": "2.47"
        }
    ],
    "TCGA-AR-A24L": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "1414",
            "bcr_followup_barcode": "TCGA-AR-A24L-F49488"
        }
    ],
    "TCGA-AR-A24O": [
        {
            "days_to_new_tumor_event_after_initial_treatment": "2561",
            "bcr_followup_barcode": "TCGA-AR-A24O-F49492"
        },
        {
            "days_to_new_tumor_event_after_initial_treatment": "2561",
            "bcr_followup_barcode": "TCGA-AR-A24O-F71713"
        }
    ],
    "TCGA-AR-A2LE": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Endometrium",
            "days_to_new_tumor_event_after_initial_treatment": "4203",
            "bcr_followup_barcode": "TCGA-AR-A2LE-F35164"
        }
    ],
    "TCGA-AR-A2LH": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "434",
            "bcr_followup_barcode": "TCGA-AR-A2LH-F35165"
        },
        {
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "434",
            "bcr_followup_barcode": "TCGA-AR-A2LH-F35165"
        },
        {}
    ],
    "TCGA-AR-A2LK": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "1304",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "bcr_followup_barcode": "TCGA-AR-A2LK-F35203"
        },
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative"
        }
    ],
    "TCGA-AR-A5QM": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "malignant melanoma",
            "days_to_new_tumor_event_after_initial_treatment": "968"
        },
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Malignant melanoma",
            "days_to_new_tumor_event_after_initial_treatment": "968",
            "bcr_followup_barcode": "TCGA-AR-A5QM-F43848"
        }
    ],
    "TCGA-AR-A5QQ": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "chestwall",
            "days_to_new_tumor_event_after_initial_treatment": "301"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "301"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "301"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "301"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Adrenal glands",
            "days_to_new_tumor_event_after_initial_treatment": "301"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "new_neoplasm_occurrence_anatomic_site_text": "Liver, bone, chest wall, adrenal glands",
            "days_to_new_tumor_event_after_initial_treatment": "301",
            "bcr_followup_barcode": "TCGA-AR-A5QQ-F42734"
        }
    ],
    "TCGA-B6-A0I1": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "1120",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "1120",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "bcr_followup_barcode": "TCGA-B6-A0I1-F38909"
        }
    ],
    "TCGA-B6-A0I9": [
        {}
    ],
    "TCGA-B6-A0WZ": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "5117",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "5117",
            "bcr_followup_barcode": "TCGA-B6-A0WZ-F71575"
        },
        {}
    ],
    "TCGA-B6-A0X1": [
        {}
    ],
    "TCGA-B6-A0X4": [
        {}
    ],
    "TCGA-B6-A0X5": [
        {}
    ],
    "TCGA-B6-A0X7": [
        {}
    ],
    "TCGA-B6-A2IU": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "4224",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-B6-A2IU-F38907"
        }
    ],
    "TCGA-B6-A3ZX": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "994",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "994",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "1096",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-B6-A3ZX-F59573"
        }
    ],
    "TCGA-B6-A402": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "breast",
            "days_to_new_tumor_event_after_initial_treatment": "1516",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "4 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "4 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Lymph Node",
            "days_to_new_tumor_event_after_initial_treatment": "2330",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "70-79%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Positive",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "2+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative",
            "her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number": "4.4",
            "metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range": "3.1",
            "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value": "4.1",
            "bcr_followup_barcode": "TCGA-B6-A402-F60751"
        }
    ],
    "TCGA-B6-A409": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "456",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "4 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "4 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        }
    ],
    "TCGA-BH-A0AW": [
        {}
    ],
    "TCGA-BH-A0AY": [
        {}
    ],
    "TCGA-BH-A0B1": [
        {}
    ],
    "TCGA-BH-A0B3": [
        {}
    ],
    "TCGA-BH-A0B4": [
        {}
    ],
    "TCGA-BH-A0B8": [
        {}
    ],
    "TCGA-BH-A0B9": [
        {}
    ],
    "TCGA-BH-A0BA": [
        {}
    ],
    "TCGA-BH-A0BC": [
        {}
    ],
    "TCGA-BH-A0BD": [
        {}
    ],
    "TCGA-BH-A0BJ": [
        {}
    ],
    "TCGA-BH-A0BM": [
        {}
    ],
    "TCGA-BH-A0BQ": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Dermis and epidermis",
            "days_to_new_tumor_event_after_initial_treatment": "1709",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "1750",
            "bcr_followup_barcode": "TCGA-BH-A0BQ-F58695"
        }
    ],
    "TCGA-BH-A0BV": [
        {}
    ],
    "TCGA-BH-A0C0": [
        {}
    ],
    "TCGA-BH-A0C1": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "1123",
            "bcr_followup_barcode": "TCGA-BH-A0C1-F63399"
        }
    ],
    "TCGA-BH-A0C3": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "2674",
            "bcr_followup_barcode": "TCGA-BH-A0C3-F63533"
        }
    ],
    "TCGA-BH-A0DH": [
        {}
    ],
    "TCGA-BH-A0DK": [
        {}
    ],
    "TCGA-BH-A0DP": [
        {}
    ],
    "TCGA-BH-A0DQ": [
        {}
    ],
    "TCGA-BH-A0DS": [
        {}
    ],
    "TCGA-BH-A0DZ": [
        {}
    ],
    "TCGA-BH-A0E0": [
        {}
    ],
    "TCGA-BH-A0E1": [
        {}
    ],
    "TCGA-BH-A0E2": [
        {}
    ],
    "TCGA-BH-A0E6": [
        {}
    ],
    "TCGA-BH-A0E7": [
        {}
    ],
    "TCGA-BH-A0EB": [
        {}
    ],
    "TCGA-BH-A0EE": [
        {}
    ],
    "TCGA-BH-A0GY": [
        {}
    ],
    "TCGA-BH-A0GZ": [
        {}
    ],
    "TCGA-BH-A0H0": [
        {}
    ],
    "TCGA-BH-A0H6": [
        {}
    ],
    "TCGA-BH-A0H7": [
        {}
    ],
    "TCGA-BH-A0H9": [
        {}
    ],
    "TCGA-BH-A0HB": [
        {}
    ],
    "TCGA-BH-A0HF": [
        {}
    ],
    "TCGA-BH-A0HI": [
        {}
    ],
    "TCGA-BH-A0HK": [
        {}
    ],
    "TCGA-BH-A0HL": [
        {}
    ],
    "TCGA-BH-A0HN": [
        {}
    ],
    "TCGA-BH-A0HO": [
        {}
    ],
    "TCGA-BH-A0HP": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative"
        }
    ],
    "TCGA-BH-A0HQ": [
        {}
    ],
    "TCGA-BH-A0HU": [
        {}
    ],
    "TCGA-BH-A0HW": [
        {}
    ],
    "TCGA-BH-A0HX": [
        {}
    ],
    "TCGA-BH-A0RX": [
        {}
    ],
    "TCGA-BH-A18J": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative"
        }
    ],
    "TCGA-BH-A18V": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative"
        }
    ],
    "TCGA-BH-A1EY": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "new_neoplasm_occurrence_anatomic_site_text": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "396",
            "bcr_followup_barcode": "TCGA-BH-A1EY-F59173"
        }
    ],
    "TCGA-BH-A1FH": [
        {}
    ],
    "TCGA-C8-A12K": [
        {}
    ],
    "TCGA-C8-A12L": [
        {}
    ],
    "TCGA-C8-A12N": [
        {}
    ],
    "TCGA-C8-A137": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "days_to_new_tumor_event_after_initial_treatment": "136",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-C8-A137-F70815"
        }
    ],
    "TCGA-C8-A3M7": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "days_to_new_tumor_event_after_initial_treatment": "1034",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-C8-A3M7-F70838"
        }
    ],
    "TCGA-D8-A13Y": [
        {}
    ],
    "TCGA-D8-A1J8": [
        {}
    ],
    "TCGA-D8-A1J9": [
        {}
    ],
    "TCGA-D8-A1JA": [
        {}
    ],
    "TCGA-D8-A1JB": [
        {}
    ],
    "TCGA-D8-A1JC": [
        {}
    ],
    "TCGA-D8-A1JD": [
        {}
    ],
    "TCGA-D8-A1JE": [
        {}
    ],
    "TCGA-D8-A1JF": [
        {}
    ],
    "TCGA-D8-A1JG": [
        {}
    ],
    "TCGA-D8-A1JH": [
        {}
    ],
    "TCGA-D8-A1JI": [
        {}
    ],
    "TCGA-D8-A1JJ": [
        {}
    ],
    "TCGA-D8-A1JK": [
        {}
    ],
    "TCGA-D8-A1JL": [
        {}
    ],
    "TCGA-D8-A1JM": [
        {}
    ],
    "TCGA-D8-A1JN": [
        {}
    ],
    "TCGA-D8-A1JP": [
        {}
    ],
    "TCGA-D8-A1JS": [
        {}
    ],
    "TCGA-D8-A1JT": [
        {}
    ],
    "TCGA-D8-A1JU": [
        {}
    ],
    "TCGA-D8-A1X8": [
        {}
    ],
    "TCGA-D8-A1X9": [
        {}
    ],
    "TCGA-D8-A1XC": [
        {}
    ],
    "TCGA-D8-A73W": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "21",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-D8-A73W-F72197"
        },
        {
            "new_tumor_event_additional_surgery_procedure": "NO"
        }
    ],
    "TCGA-E2-A108": [
        {}
    ],
    "TCGA-E2-A152": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Breast",
            "days_to_new_tumor_event_after_initial_treatment": "966",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "1044",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Positive",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "3+",
            "bcr_followup_barcode": "TCGA-E2-A152-F72471"
        }
    ],
    "TCGA-E2-A15O": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "days_to_new_tumor_event_after_initial_treatment": "289",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "289",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+",
            "bcr_followup_barcode": "TCGA-E2-A15O-F70024"
        }
    ],
    "TCGA-E2-A1IE": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "1810",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type": "Negative",
            "her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number": "2.1",
            "metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range": "2.2",
            "her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count": "200",
            "metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value": "1.0",
            "bcr_followup_barcode": "TCGA-E2-A1IE-F70297"
        }
    ],
    "TCGA-E2-A1L7": [
        {
            "new_neoplasm_event_type": "New Primary Tumor",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "left breast",
            "days_to_new_tumor_event_after_initial_treatment": "1619",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "1662",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "bcr_followup_barcode": "TCGA-E2-A1L7-F70298"
        }
    ],
    "TCGA-E2-A2P5": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "597",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-E2-A2P5-F68575"
        }
    ],
    "TCGA-E9-A1N6": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "443",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-E9-A1N6-F63536"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "days_to_new_tumor_event_after_initial_treatment": "648",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-E9-A1N6-F63536"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "672",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-E9-A1N6-F63536"
        }
    ],
    "TCGA-E9-A226": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "790",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-E9-A226-F39536"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "790",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-E9-A226-F39536"
        }
    ],
    "TCGA-E9-A2JS": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "524",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-E9-A2JS-F40293"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "524",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-E9-A2JS-F40293"
        }
    ],
    "TCGA-EW-A1P0": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "90-99%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        }
    ],
    "TCGA-EW-A1P1": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Equivocal",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        }
    ],
    "TCGA-EW-A1P8": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Negative",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "<10%"
        }
    ],
    "TCGA-GM-A2D9": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Intrathoracic lymph node",
            "days_to_new_tumor_event_after_initial_treatment": "1351",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-GM-A2D9-F47033"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "1351",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-GM-A2D9-F47033"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "536",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "536",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "bcr_followup_barcode": "TCGA-GM-A2D9-F47033"
        },
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "90-99%"
        }
    ],
    "TCGA-GM-A2DA": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "3014",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-GM-A2DA-F47040"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Liver",
            "days_to_new_tumor_event_after_initial_treatment": "4343",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "6359",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-GM-A2DA-F47040"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Intrathoracic Lymph Node",
            "days_to_new_tumor_event_after_initial_treatment": "6535",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-GM-A2DA-F47040"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Brain",
            "days_to_new_tumor_event_after_initial_treatment": "6536",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-GM-A2DA-F47040"
        },
        {}
    ],
    "TCGA-HN-A2OB": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "1543",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "4 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text": "8",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "4 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text": "Allred score=5",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "1552",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+",
            "bcr_followup_barcode": "TCGA-HN-A2OB-F71891"
        },
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "omentum",
            "days_to_new_tumor_event_after_initial_treatment": "1673",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Positive",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "2+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Negative",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "1+",
            "bcr_followup_barcode": "TCGA-HN-A2OB-F71891"
        }
    ],
    "TCGA-LL-A5YM": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Other, specify",
            "new_neoplasm_occurrence_anatomic_site_text": "Skin left chest wall",
            "days_to_new_tumor_event_after_initial_treatment": "258",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "258",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "bcr_followup_barcode": "TCGA-LL-A5YM-F57541"
        }
    ],
    "TCGA-LL-A73Z": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Brain",
            "days_to_new_tumor_event_after_initial_treatment": "192",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "NO",
            "bcr_followup_barcode": "TCGA-LL-A73Z-F64983"
        }
    ],
    "TCGA-LQ-A4E4": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "681",
            "new_tumor_event_additional_surgery_procedure": "NO",
            "additional_radiation_therapy": "YES",
            "additional_pharmaceutical_therapy": "YES",
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "bcr_followup_barcode": "TCGA-LQ-A4E4-F52290"
        }
    ],
    "TCGA-OL-A97C": [
        {
            "new_neoplasm_event_type": "Distant Metastasis",
            "new_neoplasm_event_occurrence_anatomic_site": "Lung",
            "days_to_new_tumor_event_after_initial_treatment": "275",
            "new_tumor_event_additional_surgery_procedure": "[Unknown]",
            "additional_radiation_therapy": "[Unknown]",
            "additional_pharmaceutical_therapy": "[Unknown]"
        }
    ],
    "TCGA-UL-AAZ6": [
        {
            "metastatic_breast_carcinoma_estrogen_receptor_status": "Positive",
            "metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category": "90-99%",
            "metastatic_breast_carcinoma_immunohistochemistry_er_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score": "3+",
            "metastatic_breast_carcinoma_progesterone_receptor_status": "Negative",
            "metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category": "<10%",
            "metastatic_breast_carcinoma_immunohistochemistry_progesterone_receptor_positive_finding_scale_type": "3 Point Scale",
            "metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score": "1+",
            "metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status": "Positive",
            "metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category": "50-59%",
            "metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result": "3+",
            "bcr_followup_barcode": "TCGA-UL-AAZ6-F69329"
        }
    ],
    "TCGA-Z7-A8R5": [
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "days_to_new_tumor_event_after_initial_treatment": "181",
            "new_tumor_event_additional_surgery_procedure": "YES",
            "days_to_new_tumor_event_additional_surgery_procedure": "181",
            "additional_radiation_therapy": "NO",
            "additional_pharmaceutical_therapy": "YES"
        },
        {
            "new_neoplasm_event_type": "Locoregional Recurrence",
            "new_neoplasm_event_occurrence_anatomic_site": "Bone",
            "days_to_new_tumor_event_after_initial_treatment": "3287",
            "new_tumor_event_additional_surgery_procedure": "[Unknown]",
            "additional_radiation_therapy": "[Unknown]",
            "bcr_followup_barcode": "TCGA-Z7-A8R5-F58763"
        }
    ]
}